Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

New Trauma Market Research Data Covering Multiple Geographies Released by Millennium Research Group

November 10, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

TORONTO, Nov. 10, 2010 /- Millennium Research Group (MRG), the global authority on medical technology market intelligence, has released its latest trauma research data for multiple geographies, including the US, Canada, Europe, Japan, Brazil, India, and China. MRG's trauma reports cover...

American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America

November 10, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 10, 2010 /- The American Council on Exercise (ACE), America's leading authority on fitness and the largest nonprofit fitness certification, education and training organization in the world, today announced the launch of a national campaign that will focus on eliminating...

Quotient Clinical and Bend Research Announce Collaboration to Accelerate Advancement of New Medicines

November 10, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

BEND, Ore. and NOTTINGHAM, England, Nov. 10, 2010 /- Bend Research Inc. ( www.bendres.com ), a leading independent drug-formulation development and manufacturing company, and Quotient Clinical, a business unit of Quotient Bioresearch ("Quotient," www.quotientbioresearch.com ), a leading...

Advertisement

PHC Announces 19.2% Increase in Fiscal 2011 First Quarter Revenues

November 10, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

PEABODY, Mass., Nov. 10, 2010 /- PHC, Inc., d/b/a Pioneer Behavioral Health (NYSE Amex: PHC ), a leading provider of inpatient and outpatient behavioral health services, today reported financial results for the Company's 2011 first fiscal quarter ended September 30, 2010. First Fiscal...

Global PET SPECT Market (Positron Emission Tomography) & SPECT (Single Photon Emission Computed Tomography) to be US$ 10.3 Billion by 2015

November 10, 2010 1:36 am | by Bio-Medicine.Org | News | Comments

Global PET SPECT Market (Positron Emission Tomography) & SPECT (Single Photon Emission Computed... -- DALLAS, November 10, 2010 /PRNewswi...

Biotechs, pharma look at what's next for biosimilars

November 9, 2010 7:34 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

The rubber has hit the road in the debate over legislation, approved in March, to create a regulatory pathway for generic versions of cell-based drugs known as biosimilars. The FDA has yet to issue rules on the new law, but the biotechnology world got a peek into the future landscape of...

2010 Prevention: National Lung Cancer Screening Trial Teleconference

November 9, 2010 12:37 pm | by AACR | News | Comments

Listen to this press conference with Christine Berg, M.D., of the Early Detection Research Group at the National Cancer Institute, who presented the initial results of the National Lung Cancer Screening Trial at AACR's Frontiers in Cancer Prevention Research Conference.

2010 Prevention: “Cancer Prevention Among Women” Teleconference

November 9, 2010 10:36 am | by AACR | News | Comments

Moderated by Judy Garber, M.D., M.P.H., president-elect of the American Association for Cancer Research and leader of the Center for Cancer Genetics and Prevention at the Dana-Farber Cancer Institute

Advertisement

Bradford Barton Named President, ConvaTec U.S.

November 9, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

SKILLMAN, N.J., Nov. 9, 2010 /- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced the appointment of Bradford (Brad) Barton as President, ConvaTec U.S.   Based in Skillman, NJ, Barton will lead the...

Prevention 2010: Interview with Scott M. Lippman, M.D.

November 9, 2010 6:38 am | by AACR | News | Comments

Prevention 2010: Interview with Scott M. Lippman, M.D., chair of the department of thoracic/head and neck medical oncology at the University of Texas M D Anderson Cancer Center and editor-in-chief of one of the AACR’s journals, Cancer Prevention Research

Interview with Elizabeth H. Blackburn, Ph.D.

November 9, 2010 5:34 am | by AACR | News | Comments

Prevention 2010: Interview with Elizabeth H. Blackburn, Ph.D., AACR president, 2009 Nobel Prize in Medicine or Physiology recipient, Morris Herzstein professor of biology and physiology in the department of biochemistry and biophysics at the University of California, San Francisco.

Arcadia Resources Announces Improved Fiscal 2011 Second Quarter Results

November 9, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, Nov. 9, 2010 /- Arcadia Resources, Inc. (NYSE Amex: KAD ), a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced fiscal 2011 second quarter net revenues of $25.8 million and a net loss of $2.9 million, or $0.02...

PAREXEL International to Participate in the Lazard Capital Markets Healthcare Conference in New York and the Jefferies Healthcare Summit in Boston

November 9, 2010 1:36 am | by Bio-Medicine.Org | News | Comments

BOSTON, Nov. 9, 2010 /- PAREXEL International Corporation (Nasdaq: PRXL ) announced today it will be presenting at the Lazard Capital Markets Healthcare Conference in New York.  Josef von Rickenbach, Chairman and Chief Executive Officer will be making a presentation on PAREXEL at...

Advertisement

China BCT Reschedules Conference Call to Discuss Third Quarter 2010 Results

November 9, 2010 1:35 am | by Bio-Medicine.Org | News | Comments

China BCT Reschedules Conference Call to Discuss Third Quarter 2010... -- LIUZHOU CITY, Guangxi, China, Nov. 9, 2010 /PRNewswire-Asia-FirstCall/ --

Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments

November 8, 2010 10:34 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 9, 2010 /- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) today reported financial results for the third quarter ended September 30, 2010. Arena also reported earlier today top-line results from its lorcaserin Phase 3 BLOOM-DM (Behavioral modification and Lorcaserin for...

Intercell AG Announces Q3 2010 Results and Updates on R & D Progress and Management

November 8, 2010 10:33 pm | by Bio-Medicine.Org | News | Comments

VIENNA, Nov. 9, 2010 /- Today, Intercell AG (VSE: ICLL) announced its financial results for the third quarter of 2010 and presented an update on the Company's key R&D programs as well as changes to the Management Board. Financial Results IXIARO and JESPECT sales revenues continue...

Prevention 2010: Interview with Curtis C. Harris, M.D

November 8, 2010 1:38 pm | by AACR | News | Comments

Dr. Harris discusses the topic of his distinguished lecture, inflammation and cancer and the role of infection and chronic inflammation in cancer development.

2010 Prevention: Chemoprevention Teleconference Recording

November 8, 2010 1:38 pm | by AACR | News | Comments

Moderated by Scott Lippman, M.D., editor-in-chief of Cancer Prevention Research and professor and chair in the department of thoracic head and neck medical oncology at The University of Texas MD Anderson Cancer Center

BioStorage Technologies is Set for Expansion and Growth With the Appointment of Gregory Swanberg as Chief Executive Officer

November 8, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, Nov. 8, 2010 /- BioStorage Technologies, a global leader in sample management, cold chain logistics and biomaterial storage for the pharmaceutical and biotechnology industries, today announced that the company has appointed Gregory Swanberg to serve as chief executive...

Prevention 2010: Interview with John Carpten, Ph.D.

November 8, 2010 6:33 am | by AACR | News | Comments

In this audio interview, Dr. Carpten discusses the latest genetic technology that can be used for various tumors, the potential for new treatments for many types of cancer and the African-American Hereditary Prostate Cancer Study Network.

Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2011 Financial Results

November 8, 2010 3:35 am | by Bio-Medicine.Org | News | Comments

BETHESDA, Md., Nov. 8, 2010 /PRNewswire-Asia/ -- Chindex International, Inc. (Nasdaq: CHDX ), a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced financial results for the second quarter and first half of...

Parascript Awarded $244,479.25 Affordable Care Act Grant From the U.S. Government

November 8, 2010 3:35 am | by Bio-Medicine.Org | News | Comments

LONGMONT, Colo., Nov. 8, 2010 /- Parascript, LLC, the image analysis and pattern recognition technology provider, today announced that it was awarded a cash grant of $244,479.25 under the U.S. Government's Affordable Care Act. Under this act, the therapeutic discovery project program...

Need Help Affording Your Meds? LegitScript Adds Patient Assistance Feature

November 7, 2010 10:32 pm | by Bio-Medicine.Org | News | Comments

PORTLAND, Oregon, Nov. 8, 2010 /- A leading Internet pharmacy verification service offers a new message for patients: There are ways to get affordable medicines without using unregulated, potentially dangerous "rogue" Internet pharmacies. LegitScript, a firm that monitors "rogue" Internet...

WuXi PharmaTech Awarded GLP Certificate from SFDA for Suzhou Toxicology Facility

November 7, 2010 10:32 pm | by Bio-Medicine.Org | News | Comments

SHANGHAI, Nov. 8, 2010 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it had been awarded a Certificate of Good...

Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent

November 7, 2010 8:35 pm | by Bio-Medicine.Org | News | Comments

RESEARCH TRIANGLE PARK, N.C., Nov. 7, 2010 /- Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today reaffirmed its commitment to the dual development of CMX001 as a medical countermeasure against smallpox and as a broad-spectrum antiviral...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading